Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

IGH -Mediated Translocations, Recurrent in Classic Hodgkin Lymphoma, Frequently Correlate with an Aggressive Behavior

Iwona Wlodarska, PhD, Daan Dierickx, MD PhD, Ursula Pluys, Kathleen Doms, Carlos Graux, MD PhD, Achiel Van Hoof, MD PhD, Peter Vandenberghe, MD PhD, Lucienne Michaux, MD PhD, Thomas Tousseyn

Blood (2016) 128 (22): 2922.

https://doi.org/10.1182/blood.V128.22.2922.2922

Published: 2016

Journal Articles

Pediatric ALL-like Therapy in Adults with T-Cell Lymphoblastic Lymphoma: Results of the Graall-Lysa LL03 Study

Blood (2014) 124 (21): 371.

https://doi.org/10.1182/blood.V124.21.371.371

Published: 2014

Journal Articles

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Yves Beguin, MD PhD, Pierre Zachee, MD PhD, Johan Maertens, MD PhD, Tessa Kerre, MD PhD, Aurelie Ory, Laurence Seidel, Carlos Graux, MD PhD, Philippe Lewalle, MD PhD, Michel Van Gelder, PhD MD, Koen Theunissen, Evelyne Willems, MD PhD, Marie-Paule Emonds, Ann De Becker, Frederic Baron

Blood (2014) 124 (21): 542.

https://doi.org/10.1182/blood.V124.21.542.542

Published: 2014

Journal Articles

Involvement of FER and FES in the Pathogenesis of Follicular Variant of Peripheral T-Cell Lymphoma

Iwona Wlodarska, PhD, Jo-Anne van der Krogt, Msc, Katrien Van Roosbroeck, PhD, Julio Finalet Ferreiro, Msc, Thomas Tousseyn, MD PhD, Carlos Graux, MD PhD, Daan Dierickx, MD PhD, Peter Vandenberghe, MD PhD, Jan Cools, PhD

Blood (2014) 124 (21): 5194.

https://doi.org/10.1182/blood.V124.21.5194.5194

Published: 2014

Journal Articles

Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia

Carla AL Assaf, Els Lierman, PhD, Florence Van Obbergh, MD, Timothy Devos, MD PhD, Johan Billiet, MD, Carlos Graux, MD PhD, Lucienne Michaux, MD PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD PhD

Blood (2014) 124 (21): 5584.

https://doi.org/10.1182/blood.V124.21.5584.5584

Published: 2014

Journal Articles

JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Carlos Graux, MD, PhD, Johan Billiet, MD, Peter Vandenberghe, MD, PhD

Blood (2013) 122 (21): 5258.

https://doi.org/10.1182/blood.V122.21.5258.5258

Published: 2013

Journal Articles

Screening JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia Patients For Mutations In SESN2, DNAJC17, ST13, TOP1MT , and NTRK1

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Johan Billiet, MD, Carlos Graux, MD, PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD, PhD

Blood (2013) 122 (21): 5264.

https://doi.org/10.1182/blood.V122.21.5264.5264

Published: 2013

Journal Articles

Non- IG Aberrations of FOXP1 in B-Cell Malignancies Result in an Aberrant Expression of N-Truncated FOXP1 Isoforms.

Iwona Wlodarska, PhD, Leila Rouhi, MD, Julio Finalet Ferreiro, M Sc, Thomas Tousseyn, MD PhD, Natalie Put, MD, Eugenia Haralambieva, MD, PhD, Carlos Graux, MD, PhD, Brigitte Maes, MD, PhD, Carmen Vicente, PhD, Peter Vandenberghe, MD, PhD, Jan Cools, PhD

Blood (2012) 120 (21): 2411.

https://doi.org/10.1182/blood.V120.21.2411.2411

Published: 2012

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Blood (2011) 118 (21): 159.

https://doi.org/10.1182/blood.V118.21.159.159

Published: 2011

Journal Articles

Patterns of Bone Marrow Micro Vessel Morphology in AML and High Risk MDS Predict Treatment Outcome Following Intensive Chemotherapy and Bevacizumab

Alida C. Weidenaar, Arja ter Elst, PhD, Cees AGM van Montfort, PhD, Tiny G.J. Meeuwsen-de Boer, Stefano Rosati, MD, Mario Bargetzi, MD, Carlos Graux, MD, PhD, Alois Gratwohl, MD, PhD, Bob Lowenberg, MD, PhD, Gert Ossenkoppele, MD, PhD, Evelina S. De Bont, MD, PhD

Blood (2011) 118 (21): 1555.

https://doi.org/10.1182/blood.V118.21.1555.1555

Published: 2011

Journal Articles

Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission

Edo Vellenga, MD, PhD, Wim van Putten, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Martin Fey, MD, Jurgen Kuball, MD, PhD, Matthias Theobald, MD, PhD, Jan J. Cornelissen, MD, PhD, Peter Huijgens, MD, PhD, Johan Maertens, Alois Gratwohl, MD, Martyn Ronald Schaafsma, MD, PhD, Markus G Manz, MD, Carlos Graux, MD, PhD, Bob Lowenberg, MD, PhD

Blood (2010) 116 (21): 367.

https://doi.org/10.1182/blood.V116.21.367.367

Published: 2010

Journal Articles

Deletion of the Protein Tyrosine Phosphatase Gene PTPN2 in T-Cell Acute Lymphoblastic Leukemia.

Maria Kleppe, Idoya Lahortiga, PhD, Tiama El Chaar, Kim De Keersmaecker, PhD, Nicole Mentens, Carlos Graux, MD, PhD, Katrien Van Roosbroeck, Adolfo A. Ferrando, MD, PhD, Anton W Langerak, PhD, Jules P.P. Meijerink, PhD, Francois Sigaux, MD, Torsten Haferlach, MD, Iwona Wlodarska, PhD, Peter Vandenberghe, MD, PhD, Jean Soulier, MD, PhD, Jan Cools, PhD

Blood (2009) 114 (22): 141.

https://doi.org/10.1182/blood.V114.22.141.141

Published: 2009

NARROW

IGH -Mediated Translocations, Recurrent in Classic Hodgkin Lymphoma, Frequently Correlate with an Aggressive Behavior

Pediatric ALL-like Therapy in Adults with T-Cell Lymphoblastic Lymphoma: Results of the Graall-Lysa LL03 Study

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation Following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: A Phase II Randomized Study from the Belgian Hematological Society

Involvement of FER and FES in the Pathogenesis of Follicular Variant of Peripheral T-Cell Lymphoma

Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia

JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study

Screening JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia Patients For Mutations In SESN2, DNAJC17, ST13, TOP1MT , and NTRK1

Non- IG Aberrations of FOXP1 in B-Cell Malignancies Result in an Aberrant Expression of N-Truncated FOXP1 Isoforms.

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Patterns of Bone Marrow Micro Vessel Morphology in AML and High Risk MDS Predict Treatment Outcome Following Intensive Chemotherapy and Bevacizumab

Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission

Deletion of the Protein Tyrosine Phosphatase Gene PTPN2 in T-Cell Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only